Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification

NCT05259605 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.

NCT NCT05259605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05259605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Phase
Observational
Overall status
Recruiting
Start date
March 21, 2023
Completion date
July 29, 2038
Enrollment
1,650 (estimated)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

choroid plexus tumor, diffuse midline glioma, h3 k27m-mutant, embryonal tumor, ependymoma, germ cell tumor, glioma, glioneuronal tumor, hemangioblastoma, hemangiopericytoma, melanocytic tumor of cns, pineal tumor, pineal tumors, tumor of the sellar region